Novanta (NOVT)
NASDAQ:NOVT
Want to see NOVT full AI Analyst Report?
Earnings Data
Report Date
Aug 11, 2026Before Open (Confirmed)
Period Ending
2026 (Q2)Consensus EPS Forecast
0.83Last Year’s EPS
0.76Same Quarter Last Year
Moderate Buy
Based on 2 Analysts Ratings
Earnings Call Summary
Earnings Call Sentiment|Positive
The call conveyed strong operational momentum: robust bookings (+37%), improving organic growth trajectory, expanding profitability (adjusted EBITDA +14%, margin +70 bps), accelerating new product revenue (+~50%) and excellent cash generation (>200% cash conversion). These positives were tempered by near-term gross margin pressure from sudden tariff and freight cost increases, a modest $0.03 EPS headwind, and timing risk as repricing and manufacturing consolidation benefits are expected to materialize in the back half of the year. Management reaffirmed and tightened full-year guidance and outlined clear actions (surcharges, price increases, site consolidations) to restore margins, leaving the overall tone constructive.Company Guidance
Revenue Growth and Upgraded Guidance
Q1 reported revenue grew 10% year-over-year with 3% organic growth (an inflection versus the prior quarter). Management raised full-year GAAP revenue guidance to $1,040M–$1,055M (reported growth >7%, organic growth up to 6%) and expects Q2 organic growth of 6%–8%.
Strong Bookings and Backlog
Bookings increased 37% year-over-year with a book-to-bill of 1.10, all businesses delivered double-digit bookings growth, and management cites a growing committed backlog supporting the 2026 outlook.
Improving Profitability
Adjusted EBITDA grew 14% year-over-year to $57M and adjusted EBITDA margin expanded by ~70 basis points to 22%. Adjusted diluted EPS was $0.81, up 9% year-over-year. Full-year adjusted EBITDA guidance $245M–$250M (+11%–13%) and adjusted EPS guidance $3.50–$3.65 (+6%–11%).
Excellent Cash Flow and Balance Sheet Position
Operating cash flow rose 63% year-over-year to $52M and cash flow conversion to net income was >200% in the quarter. Q1 cash balance was $389M, gross debt $249M, net cash position of $139M (net leverage -0.6x). The company repurchased ~$18M of stock in the quarter.
New Product Momentum and Design Wins
New product revenue grew ~50% year-over-year and the Vitality Index reached 27% of sales. Company-wide design wins rose nearly 30% year-over-year; Automation segment new product revenue grew >70% and Medical Solutions new product sales grew ~45%.
Broad-Based Segment Strength
Medical Solutions revenue grew 15% YoY (Advanced Surgery +11%, Precision Medicine +18% driven by Keonn acquisition). Robotics & Automation revenue +7% YoY with bookings up 50%. Precision Manufacturing returned to mid-single-digit revenue growth (+6%) with its fifth consecutive quarter of double-digit bookings growth.
Exposure to GenAI/Semiconductor Tailwinds
Approximately 15% of company revenue was tied to GenAI-related data center and advanced semiconductor applications in Q1, which grew ~20% YoY and are expected to accelerate. Company joined NVIDIA Halos AI Systems Inspection Lab, underscoring positioning in safety-validated AI-driven robotics.
Operational & Strategic Progress
Management is executing a regional manufacturing consolidation (two facility closures on track for Q2) to drive H2 gross margin improvement, maintains a deep acquisition pipeline and plans disciplined capital deployment to accelerate strategic priorities.
NOVT Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
NOVT Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
May 11, 2026 | $139.98 | $159.19 | +13.72% |
Feb 23, 2026 | $142.38 | $137.44 | -3.47% |
Nov 03, 2025 | $135.86 | $129.33 | -4.81% |
Aug 05, 2025 | $124.01 | $115.70 | -6.70% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
FAQ
When does Novanta (NOVT) report earnings?
Novanta (NOVT) is schdueled to report earning on Aug 11, 2026, Before Open (Confirmed).
What is Novanta (NOVT) earnings time?
Novanta (NOVT) earnings time is at Aug 11, 2026, Before Open (Confirmed).
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is NOVT EPS forecast?
NOVT EPS forecast for the fiscal quarter 2026 (Q2) is 0.83.